MedTrace Logo

Supplemental Thiamine in Septic Shock: A Before-after Study

NCT05840718 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 73

Last updated 2024-04-18

No results posted yet for this study

Summary

This controlled before-and-after study analyse the impact of thiamine supplementation on outcomes of patients with septic shock treated according to the surviving sepsis campaign 2021 guidelines

Conditions

  • Septic Shock

Interventions

DRUG

Thiamin

Patients in thiamine group received two daily dosis of 200 mg of thiamin diluted in 50 ml of 5% dextrose during 7 days

Sponsors & Collaborators

  • Hospital Sao Domingos

    lead OTHER

Principal Investigators

  • ISNARA S CARVALHO, RN · Hospital Sao Domingos

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2023-11-30
Completion
2023-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05840718 on ClinicalTrials.gov